Have a personal or library account? Click to login
Acylcarnitines’ Level in the Dried Blood Spot Samples of Healthy Newborns in Serbia-The Pilot Study Cover

Acylcarnitines’ Level in the Dried Blood Spot Samples of Healthy Newborns in Serbia-The Pilot Study

EABR. Experimental and Applied Biomedical Research
Volume 24 (2023): Issue 3 (September 2023)
By: Andjelo Beletic,  Aleksandra Tijanic,  Tatjana Nikolic,  Petr Chrastina,  Aleksandar Stefanovic and  Sanja Stankovic  
Open Access
|Sep 2023

Authors

Andjelo Beletic

andjelobeletic78@gmail.com

Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia

Aleksandra Tijanic

Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia

Tatjana Nikolic

Clinic for Gynecology and Obstetrics, Clinical Centre of Serbia, Belgrade, Serbia

Petr Chrastina

Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

Aleksandar Stefanovic

Clinic for Gynecology and Obstetrics, Clinical Centre of Serbia, Belgrade, Serbia
University of Belgrade, Faculty of Medicine, Belgrade, Serbia

Sanja Stankovic

Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia
DOI: https://doi.org/10.2478/sjecr-2021-0021 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 193 - 198
Submitted on: Nov 22, 2020
Accepted on: Jan 2, 2021
Published on: Sep 29, 2023
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Acylcarnitines,
newborns,
fatty acid oxidation,
tandem mass spectrometry,
Serbia
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2023 Andjelo Beletic, Aleksandra Tijanic, Tatjana Nikolic, Petr Chrastina, Aleksandar Stefanovic, Sanja Stankovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 24 (2023): Issue 3 (September 2023)Next article